Liem Nguyen Thanh
Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti-N-Methyl-d-Aspartate Receptor Encephalitis: First Case Report
Nguyen Thanh, Liem; Hoang, Van T.; Le Thu, Huong; Nguyen, Phuong Anh Thi; Hoang, Duc M.; Ngo, Doan Van; Cao Vu, Hung; Nguyen Thi Bich, Van; Heke, Michael
Authors
Van T. Hoang
Huong Le Thu
Phuong Anh Thi Nguyen
Dr Harry Hoang Harry.Hoang@nottingham.ac.uk
Research Fellow
Doan Van Ngo
Hung Cao Vu
Van Nguyen Thi Bich
Michael Heke
Abstract
Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis is caused by altered patient immune reactions. This study reports the first patient with severe neurologic sequelae after NMDA receptor encephalitis treated with allogeneic umbilical cord–derived mesenchymal stem/stromal cells (UC-MSCs). A 5-year-old girl was diagnosed with NMDA receptor encephalitis and treated with immunosuppressive medicaments and intravenous immunoglobulin (IVIG). Despite intensive therapy, the patient’s condition worsened so that allogenic UC-MSC therapy was contemplated. The patient received three intrathecal infusions of xeno- and serum-free cultured UC-MSCs at a dose of 106 cells/kg. At baseline and after each UC-MSC administration, the patient was examined by the German Coma Recovery Scale (CRS), the Gross Motor Function Classification System (GMFCS), the Gross Motor Function Measure–88 (GMFM-88), the Manual Ability Classification System (MACS), the Modified Ashworth Scale, and the Denver II test. Before cell therapy, she was in a permanent vegetative state with diffuse cerebral atrophy. Her cognition and motor functions improved progressively after three UC-MSC infusions. At the last visit, she was capable of walking, writing, and counting numbers. Control of urinary and bowel functions was completely recovered. Cerebral atrophy was reduced on brain magnetic resonance imaging (MRI). Overall, the outcomes of this patient suggest a potential cell therapy for autoimmune encephalitis and its neurological consequences.
Citation
Nguyen Thanh, L., Hoang, V. T., Le Thu, H., Nguyen, P. A. T., Hoang, D. M., Ngo, D. V., Cao Vu, H., Nguyen Thi Bich, V., & Heke, M. (2022). Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti-N-Methyl-d-Aspartate Receptor Encephalitis: First Case Report. Cell Transplantation, 31, https://doi.org/10.1177/09636897221110876
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 15, 2022 |
Online Publication Date | Jul 11, 2022 |
Publication Date | Jul 11, 2022 |
Deposit Date | Oct 19, 2024 |
Publicly Available Date | Oct 22, 2024 |
Journal | Cell Transplantation |
Print ISSN | 0963-6897 |
Electronic ISSN | 1555-3892 |
Publisher | Cognizant Communication Corporation |
Peer Reviewed | Peer Reviewed |
Volume | 31 |
DOI | https://doi.org/10.1177/09636897221110876 |
Keywords | autoimmune encephalitis, anti-NMDA receptor encephalitis, neurological sequelae, mesenchymal stem cells, mesenchymal stromal cells |
Public URL | https://nottingham-repository.worktribe.com/output/40563110 |
Publisher URL | https://journals.sagepub.com/doi/10.1177/09636897221110876 |
Files
nguyen-thanh-et-al-2022-human-umbilical-cord-mesenchymal-stem-cells-for-severe-neurological-sequelae-due-to-anti-n
(4 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
Copyright Statement
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-
NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and
distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages
(https://us.sagepub.com/en-us/nam/open-access-at-sage).
You might also like
iMSC: One leap closer to clinical applications
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search